Commentary

• Regions and Countries

  • Asia & Pacific
  • China
  • East Asia
  • South-East & North-East Asia
  • South Asia
  • West Asia/Middle East
  • Central Asia(Transcaucasia)
  • Africa
  • North Africa
  • Sub-Sahara Africa
  • South Africa
  • Europe
  • Russia
  • America
  • Latin America & the Caribbean
  • US & Canada
  • Australia & New Zealand
  • Arctic and Antarctic

   

• Research Programs

  • IR & Foreign Affairs
  • Politics & Government
  • Economy & Trade
  • Defense & Security
  • Global Governance
  • Energy & Environment
  • Cross-Strait Relations & HongKong & Macao Studies
  • History & Culture

   

• Topics

  • COVID-19
  • SCO
  • BRICS
  • Diplomatic Theory with Chinese Characteristics
  • One Belt & One Road
  • AIIB Studies
  • New Type of China-US Major Power Relations
  • China-Africa Cooperation
  • G20 studies
  • Anti-Terrorism
  • Arctic & Antarctic Studies
  • South China Sea Issue
  • Cybersecurity

   

• ‘Cheaper costs than China’ not adequate to lure Tesla to India

  2021-03-04

  Liu Zongyi

  Illustration: Tang Tengfei/GT In New Delhi's latest efforts to bolster India's manufacturing capa

• China’s return as India’s top trader blow against nationalism

  2021-02-25

  Liu Zongyi

  China returned as the largest trading partner of India in 2020 - an extreme year for bilateral relations as New Delhi

• Iran Nuclear Issue: Dual-Track Wisdom

  2021-02-19

  Jin Liangxiang

  Jan. 20 saw Joseph Biden’s smooth inauguration as president of the United States for at least the next four year

• Redress the balance

  2021-02-10

  Zhou Yuyuan

  An international debt management system should be established to strike an effective equilibrium between debt sustain

• India’s plan on issuing official digital currency premature

  2021-02-03

  Liu Zongyi

  As countries, especially developed economies, are paying accelerating efforts on developing official digital curr

• Economic policy revision more important than boasting about India’s recovery

  2021-01-21

  Liu Zongyi

  Since the India drug regulator's hastened approval of its COVID-19 vaccine over the weekend, market con